Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Active substance : eltrombopag
  • Topics : Blood and lymphatic diseases
  • Topics : Blood coagulation and hemostasis disorders
  • Language : Français
Filter
Topic
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Drug therapy (1)
  • Diseases and conditions (1)
  • Plus ...
    • Infectious diseases (1)
    • Plus ...
      • Virus diseases (1)
    • Congenital, genetic and rare diseases (1)
    • Blood and lymphatic diseases (1)
    • Plus ...
      • Blood coagulation and hemostasis disorders (1)
      • Bone marrow diseases (1)
      • Anemia and hemoglobinopathies (1)
    • Digestive system diseases (1)
    • Plus ...
      • Liver diseases (1)
    • Immune system diseases (1)
    • Plus ...
      • Autoimmune diseases (1)
  • Population groups (1)
  • Plus ...
    • Paediatrics (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Medicine (1)
Date
  • Last five years (1)
Language
  • Français (1)
Active substance
  • eltrombopag (1)

Drugs, devices and medical acts - 1 result

  • REVOLADE (eltrombopag)

    Medicine - Posted on 4/3/2020 - Mis à jour le 4/3/2020
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
eNq9WG1v2jAQ/s6vQEjsG6ShpcCWUFFeWqR2YwW2aV8ikxwQZuzUdijdr5+TUJF2oTCDJ7VS8MtzZ9+T5+5iXa2XOL8Cxn1K7IJZPivkgbjU88nMLoxHvVK9cNXMWQu0Qull9fKZY9bNQt7FiHO7EM2XJ4AIL/+4v+uARABWaObyFp0swBWv1oXCx+VbxOf3KIjW5K0V9b38EsScenYhCEU8mre4YNKP5hNlv3iAXLCMzUh6duFcpMctIwI7ADXkwO4QmWWCAlHCdEPGgIg2EjCj7DkTeuo6lXrtolE5VzLh8wfgNGQuDJCYDxhd+R542ZYQ5qBkZPrkDYGtMIjISCa4sXCXXAkcLdD6AR772U635GxbrEXprGRe1hoN+VdtNOoNJVMsdVXZ5JGHMJKIVM2aaQAx5J4QCyRKHpQYuHNg8l8xVAPKBMKaguTz9mu6abLD4HEvGTyfBxg9lxc8UL0qxJCcBiZFQd9BohOMmJQpLO/sDT4JMTb+0evxRkQ0eRxpVJuGROzQkvFQ9SLalAhY746omvyJ9YaLPvDTwf6mJFv6B+EE+66qwkkNCoGL8UN/t8Bp1IZrxGHM9InDd5949ImfXnTSQdbkfRDrZiZowDzTqTTql2a1qvxO/ZSM2pF/uiGjARhSjnx+jMr0yZQeqy+SpNlQLxTVxc64NqIuwrCjOnIUlUfS8qWY00Z8fS9VMpEJetMdqbLlawjseRj/zIT2PXsbZzVd1iH2kpz7PI+M2h/QMvgklkGc4G3xHACfFs87QhKUUExnUkWKld4MCLAoJ5e7K4RDJGSj0QE+Sq3qwBDJc8R4NBgCkvRO0BO5sNPSEI/3Wu3uyBnddu+7tutcXlxWL6Sp+Kl26hV3rc83Tvxo92SBUWyfF1s15PMTLmEQYHkPtnmW2jEcXzut9qj/rWsDFowuJzRAs/2ux0+mKTnVqByh0Qe0Ouc1xeo9ZNkpYC5EwD8axhzxEo8oUZ6yg7P11ZaUOoj5NznfI+hhBPuvq9K8eLPjXXKeftkbuu+jvGo5s9VGfc20lmo76T6SUkaT65OkRj38LVTNgftq8WP7y83+TR+bnaxYCEfEISmXtBU1/e7p66Rtc6nN7cGrJKHPTNwIxtqsqyMJJ++kOOXKTAaW9JhUhy/Tqb/jA+dOYlpG8nG1mbOM6MNqM/cHv+4d5w==
Dp2v85mzUVV9aXRu